Blog Archives

Pharma’s Direct-to-Patient Pivot (2025): LillyDirect, PfizerForAll & NovoCare Models

By Galen Growth Research — Updated 09 September 2025 Big Pharma is moving from DTC advertising to Direct-to-Patient (DTP) infrastructure—brand-owned digital front…

How Generative AI Will Reshape Digital Health Startups – and What They Must Do to Adapt

TLDR According to Galen Growth, at least 65% of global Digital Health companies operate with a B2B business model or a hybrid,…

European Digital Health Bucks The Trend

The European Digital Health landscape is undergoing a significant transformation, evolving beyond the initial hype to a phase where tangible results and…

HealthTech 250 Thriving Amid Adversity – Mid-2025 Trends & Outlook

Galen Growth’s Unmatched Intelligence Identifies Digital Health’s Future Leaders This is Part 2 of our two-part series on the HealthTech 250 —…

Generative AI in Healthcare: From Pilots to Proven Impact

Why is generative AI becoming central to healthcare and pharma? A recent report from MIT’s NANDA initiative reveals a sobering reality: 95%…

Epic Joins the AI Scribe Race: Can Startups Still Win?

The entry of the electronic health record giant into the ambient scribe market marks a turning point—but does it spell the end…

HealthTech 250 Mid-Year 2025 Check-In: Weathering a Tumultuous Year

Part one of our mid-year HealthTech 250 review Each year, Galen Growth, the leading authority on digital health intelligence, publishes its HealthTech…

POV: “Make Health Tech Great Again” — Decoding the White House–CMS Announcement for Digital Health

On 30 July 2025, the White House and Centers for Medicare & Medicaid Services (CMS) announced a voluntary CMS Interoperability Framework, a…

U.S. Digital Health Funding in Q2 2025: A Maturing Ecosystem with Healthcare Impact

AI dominates funding flows, but only ventures delivering clinical and operational impact make the cut TL;DR – Key Takeaways U.S. digital health…

APAC Digital Health Funding in Q2 2025: AI-Driven Momentum in a Shifting Global Landscape

TL;DR $1.2B raised across 102 deals in APAC, marking 4% YoY growth despite an 11% global decline. AI-powered ventures secured 63% of…

Proof Over Promise: H1 2025 Marks a Turning Point in Digital Health Funding

Venture capital funding in H1 2025 favoured fewer, larger bets, rewarding clinical proof and late-stage maturity over early-stage hype. TL;DR What is…

Digital Health Exits: Navigating 2025’s Shifting Tides Towards Maturity

Unpacking the Surge in M&A and the Cautious Re-emergence of IPOs in a Transforming Landscape The global digital health sector has witnessed…

Articles in Blog

Articles

Overview

Category

Stage

Total Funding

GGA Score